Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSTU vs GSK✓SelectedUSD · GSKMSTU vs GSK performance historyLatest closeAs of-9.42%11/19
Stock and ETF performance explorer

MSTU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-95.6%
GSK return
+22.0%
Excess return
-117.5%
Maximum drawdown
-99.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.4%-1.6%-7.9%-9.8%
7D-44.6%-4.7%-39.9%-45.3%
30D-66.3%-4.7%-61.6%-66.6%
3M-46.4%-8.8%-37.7%-47.5%
6M-83.1%-4.6%-78.4%-83.2%
YTD-86.4%+1.0%-87.4%-85.8%
1Y-91.7%+6.9%-98.5%-91.0%
All-95.6%+22.0%-117.5%-94.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling